Antiphospholipid syndrome (APS) is an autoimmune disease that demonstrates antiphospholipid antibodies that cause hypercoagulability and leads to venous and arterial thrombosis. Autoantibodies to a disintegrin-like and metalloprotease with thrombospondin type I motif, member 13 (ADAMTS 13) play a role in the microthrombosis of thrombotic thrombocytopenic purpura in APS patients.
Keywords: ADAMTS13; antiphospholipid syndrome; disintegrin‐like and metalloprotease; thrombotic thrombocytopenic purpura.
© 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.